Clinical Immunology, Neuropharmacology and Drug Development

Microbiome-Targeted Therapies in Neurology

This track focuses on the role of the gut-brain axis and microbiome in neurological health and disease. Researchers are invited to submit abstracts on microbiome-targeted therapies, including probiotics, prebiotics, and dietary interventions, that influence neuroimmune and neuropharmacological outcomes. The track will explore the mechanisms by which the microbiome affects neurological function and the potential for microbiome-based treatments in conditions such as autism, depression, and multiple sclerosis. Attendees will gain insights into how manipulating the microbiome can offer novel therapeutic avenues in neurology.